1. Home
  2. TLSI vs ELME Comparison

TLSI vs ELME Comparison

Compare TLSI & ELME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$5.43

Market Cap

274.3M

Sector

Health Care

ML Signal

HOLD

Logo Elme Communities

ELME

Elme Communities

HOLD

Current Price

$2.94

Market Cap

271.5M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLSI
ELME
Founded
2010
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
274.3M
271.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TLSI
ELME
Price
$5.43
$2.94
Analyst Decision
Strong Buy
Hold
Analyst Count
2
4
Target Price
$11.50
$14.25
AVG Volume (30 Days)
118.9K
6.2M
Earning Date
11-13-2025
02-12-2026
Dividend Yield
N/A
24.32%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,207,000.00
$246,959,000.00
Revenue This Year
$55.47
N/A
Revenue Next Year
$40.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
49.52
3.10
52 Week Low
$3.42
$2.70
52 Week High
$7.95
$18.08

Technical Indicators

Market Signals
Indicator
TLSI
ELME
Relative Strength Index (RSI) 38.68 6.82
Support Level $5.24 $2.70
Resistance Level $5.87 $3.11
Average True Range (ATR) 0.41 0.14
MACD -0.09 -0.50
Stochastic Oscillator 18.35 1.61

Price Performance

Historical Comparison
TLSI
ELME

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.

Share on Social Networks: